Registration, incidence patterns, and survival trends of central nervous system tumors among children in Germany 1980-2019: An analysis of 40 years based on data from the German Childhood Cancer Registry

被引:1
|
作者
Wellbrock, Maike [1 ,2 ,4 ]
Voigt, Mathias [3 ]
Ronckers, Cecile [3 ]
Grabow, Desiree [3 ]
Spix, Claudia [3 ]
Erdmann, Friederike [1 ,2 ]
机构
[1] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Biostat Epidemiol & Informat IMBEI, Res Grp Aetiol & Inequal Childhood Canc,Div Childh, Mainz, Germany
[2] Leibniz Inst Prevent Res & Epidemiol BIPS, Dept Prevent & Evaluat, Bremen, Germany
[3] Johannes Gutenberg Univ Mainz, Univ Med Ctr, German Childhood Canc Registry, Div Childhood Canc Epidemiol,Inst Med Biostat Epid, Mainz, Germany
[4] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Biostat Epidemiol & Informat IMBEI, Div Childhood Canc Epidemiol,Res Grp Aetiol & Ineq, Langenbeckstr 1, D-55131 Mainz, Germany
关键词
childhood cancer; German Childhood Cancer Registry; incidence; pediatric central nervous system tumors; survival; time trends; BRAIN-TUMORS; RADIATION-EXPOSURE; SOCIOECONOMIC DISPARITIES; RISK-FACTORS; CNS TUMORS; CLASSIFICATION; EPIDEMIOLOGY; EUROPE; SWEDEN; BIRTH;
D O I
10.1002/pbc.30954
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundTumors of the central nervous system (CNS) are the second most common type of pediatric cancer in Germany. We aimed to describe registration practice, incidence, and survival patterns for childhood CNS tumors in Germany for the past 40 years.ProcedureIncluding all CNS tumor cases in children diagnosed at ages 0-14 years registered at the German Childhood Cancer Registry (GCCR) in 1980-2019 (for survival analysis 1980-2016), we calculated age-specific and age-standardized incidence rates (ASIR) over time, average annual percentage changes (AAPC), and 1- and 5-year overall survival.ResultsWhile we observed a pronounced increase in ASIR after the establishment of the GCCR during the 1980s, ASIR for all pediatric CNS tumors combined continued to increase markedly from 28.6 per million in 1990-1999 to 43.3 in 2010-2019 (AAPC = 2.7% in 1991-2010, AAPC = 0.3% in 2010-2019). The 5-year overall survival from CNS tumors improved from 63% in the 1980s, 70% in the 1990s to 79% in 2010-2016. These improvements have occurred across all age groups. Children diagnosed with ependymomas and choroid plexus tumors experienced the strongest increase (from 54% to 81%).ConclusionsObserved increases in incidence rates for pediatric CNS tumors are likely only partially caused by actual increasing case numbers. The majority is a function of improved registration and, to a minor extent, improvements in diagnostics. Survival from pediatric CNS tumors has, by and large, improved consistently, leading to a growing population of childhood cancer survivors with diverse health biographies and risk of lifelong adverse impact on health and wellbeing.
引用
收藏
页数:14
相关论文
共 3 条
  • [1] Incidence and Temporal Patterns of Differentiated Thyroid Carcinoma in Children and Adolescents in Germany: A Pooled Analysis Based on Data from the German Malignant Endocrine Tumor Registry and the German Childhood Cancer Registry
    Kuhlen, Michaela
    Wellbrock, Maike
    Kunstreich, Marina
    Truebenbach, Claudia
    Ronckers, Cecile
    Redlich, Antje
    Erdmann, Friederike
    THYROID, 2024, 34 (12) : 1540 - 1550
  • [2] Incidence trends in pediatric central nervous system tumors in Canada: a 15 years report from Cancer and Young People in Canada (CYP-C) registry
    Larouche, Valerie
    Toupin, Annie-Kim
    Lalonde, Benoit
    Simonyan, David
    Jabado, Nada
    Perreault, Sebastien
    NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [3] CLINICOPATHOLOGICAL FEATURES, SURVIVAL AND PROGNOSTIC FACTORS OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS - TRENDS IN INCIDENCE OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMAS AND PRIMARY MALIGNANT BRAIN-TUMORS IN A WELL-DEFINED GEOGRAPHICAL AREA - POPULATION-BASED DATA FROM THE DANISH LYMPHOMA REGISTRY, LYFO, AND THE DANISH CANCER REGISTRY
    KROGHJENSEN, M
    DAMORE, F
    JENSEN, MK
    CHRISTENSEN, BE
    THORLING, K
    PEDERSEN, M
    JOHANSEN, P
    BOESEN, AM
    ANDERSEN, E
    LEUKEMIA & LYMPHOMA, 1995, 19 (3-4) : 223 - 233